High Mark Wealth Management LLC Invitae Corp Transaction History

High Mark Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$6.28 - $15.59 $295 - $732	-47 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$14.7 - $28.67 $3,175 - $6,192	-216 Reduced 82.13%	47 $1,000
Q3 2021 Nov 01, 2021	BUY	$24.31 - $33.6 $729 - $1,008	30 Added 12.88%	263 $7,000
Q2 2021 Aug 02, 2021	BUY	$26.09 - $40.4 $652 - $1,010	25 Added 12.02%	233 $8,000
Q1 2021 Apr 22, 2021	BUY	$33.06 - $56.93 $5,322 - $9,165	161 Added 342.55%	208 $8,000
Q1 2020 Apr 30, 2020	BUY	$7.64 - $27.5 $359 - $1,292	47 New	47 $0

2.08M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on High Mark Wealth Management LLC with notifications on news.